GlaxoSmithKline restructures ahead of Lucozade and Ribena sell-off
GlaxoSmithKline (GSK) is splitting the company into two separate business operations to pave the way for a selling off of the Lucozade and Ribena brands.
Lucozade Sport: footballer Gareth Bale features in the latest campaign by Grey London
Peter Harding will lead the Lucozade and Ribena business, while the GSK Consumer Healthcare business, which spans oral health, wellness, nutrition and skin health, will be led by new general manager Carlton Lawson.
Harding’s management team includes the appointment of Carol Smith as
GSK insists it will continue developing new products and investing in advertising and promotional spend into the Lucozade and Ribena brands as it prepares for a sale.
Harding said: "Lucozade and Ribena are two of the most recognised brands in
"My goal is to continue to drive success on Lucozade and Ribena by executing our highly competitive plans for 2013."
Lawson will be supported in his new role by Jon Workman, vice-president of sales, Rachel Deans, marketing, and Dave Barrett, commercial director
GSK Consumer Healthcare brands include Sensodyne, Aquafresh, Beechams, Panadol, NiQuitin and Maxinutrition.
This article was first published on marketingmagazine.co.uk
Latest jobs Jobs web feed
- Account Director - Top London Advertising Agency c£50k Fill Recruitment Ltd c£50k, Central London
- Senior Brand Manager Ball & Hoolahan £55,000 + Car/Car Allowance, London
- Senior CRM Planner Direct Recruitment £80,000 - £95,000, Central London
- Planner Direct Recruitment Up to 60k plus benefits, Central London
- Junior Recruitment Consultant, Insight Team Hasson Associates £Competitive , Central London
- UK Digital Lead Hasson Associates £70,000 - £83,000, Central London